Itaconix plc (AIM:ITX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
SPARXTM Formulated Solutions	2.86M	1.73M	1.91M	992.00K	342.00K
SPARXTM Formulated Solutions Growth	65.38%	-9.33%	92.34%	190.06%	-
Itaconix Performance Ingredients	7.64M	4.77M	5.96M	4.61M	2.25M
Itaconix Performance Ingredients Growth	60.03%	-19.89%	29.30%	104.44%	-
Total	10.50M	6.50M	7.87M	5.60M	2.60M
Total Growth	61.45%	-17.33%	40.46%	115.72%	-21.14%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North America	6.54M	4.56M	6.90M	5.08M	2.41M
North America Growth	43.51%	-33.97%	35.84%	110.71%	-16.00%
Europe, Middle East and Africa	3.96M	1.94M	-	-	-
Europe, Middle East and Africa Growth	104.44%	-	-	-	-
Rest of World	-	10.00K	-	-	-
Europe	-	-	968.00K	522.00K	186.00K
Europe Growth	-	-	85.44%	180.65%	-56.03%
Total	10.50M	6.50M	7.87M	5.60M	2.60M
Total Growth	61.45%	-17.33%	40.46%	115.72%	-21.14%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 5, 2026

Data Sources Report a data error